Cite
HARVARD Citation
Sternschuss, M. et al. (2020). Can Ipilimumab restore immune response in advanced NSCLC after progression on anti‐PD‐1/PD‐L1 agents?. Thoracic cancer. 11 (8), pp. 2331-2334. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sternschuss, M. et al. (2020). Can Ipilimumab restore immune response in advanced NSCLC after progression on anti‐PD‐1/PD‐L1 agents?. Thoracic cancer. 11 (8), pp. 2331-2334. [Online].